Sarepta Therapeutics
$6.22 B
Share price
Change (1 day)
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Market capitalization of Sarepta Therapeutics (SRPT)

Market cap: $6.22 Billion

As of May 2022 Sarepta Therapeutics has a market cap of $6.22 Billion. This makes Sarepta Therapeutics the world's 1986th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Sarepta Therapeutics from 2001 to 2022

Year Market cap Change
2022$6.22 B-20.63%
2021$7.84 B-41.72%
2020$13.45 B38.67%
2019$9.70 B25.09%
2018$7.75 B115.68%
2017$3.59 B140.16%
2016$1.49 B-14.94%
2015$1.76 B194.49%
2014$0.59 B-22.27%
2013$0.76 B-5.98%
2012$0.81 B708.83%
2011$0.10 B-57.54%
2010$0.23 B47.65%
2009$0.16 B244.53%
2008$0.04 B-48.47%
2007$0.09 B-46.27%
2006$0.16 B-4.22%
2005$0.17 B107.9%
2004$0.08 B-39.45%
2003$0.14 B5.62%
2002$0.13 B-47.63%
2001$0.25 B

End of Day market cap according to different sources

On May 21st, 2022 the market cap of Sarepta Therapeutics was reported to be:

$6.22 Billion
by Nasdaq
$6.22 Billion
by CompaniesMarketCap
$6.19 Billion
by Yahoo Finance
$6.22 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$80.07 B 1,186.57%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.30 B-62.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.17 B-32.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$15.98 B 156.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.42 B-61.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.68 B-72.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.64 B-89.65%๐Ÿ‡บ๐Ÿ‡ธ USA